WITH SMES,

INVEST IN OUR FUTURE
WITH SMES,

INVEST IN OUR FUTURE
WITH SMES,

INVEST IN OUR FUTURE

A targeted investment strategy

Xerys is a portfolio management company specialising in private equity with an approach that makes the entrepreneur’s vision central to its investment philosophy. It aims to support the managers of Xerys Funds portfolio companies at all stages of their growth, from venture capital to maturity.

JACQUES SIMONNET

Chairman of the supervisory board and founder

OLIVIER OSSIPOFF

Chairman

OUR PHILOSOPHY

The Xerys approach

« The creation of Xerys aims to meet the need to reconcile two major issues for business growth. On the one hand, entrepreneurs who wish to successfully carry out their growth ambitions need tailored, financial guidance but also strategic and operational support. On the other hand, investors are looking for transparency and control of their investments.…

AN ORIGINAL APPROACH TO A CAPITAL INVESTOR

100%

INDEPENDENT

€10-60K

INVESTMENT
TICKET

12

PORTFOLIO
COMPANIES

2014

Approval of the Authority
Financial Markets

Strong expertise

The governance of Xerys Gestion is structured around a supervisory board and a directory with complementary experiences

Strong involvement

The management team and the experts are involved in the monitoring of the participations

Convergent interests

The management team is systematically interested in the performance of investments

Xerys therefore immediately establishes a constructive and proactive proximity relationship with the managers of its investments to assist and advise them in their strategic decision-making, arbitration and value creation.
With this original approach, Xerys establishes a relationship of trust with managers and investors, fostering a creation of shared value over the medium term.

3 SECTORS OF INVESTMENT

Santé

Sustainable
development

Connected
Technologies

NEWS

Biolog-id LLC Partners with LifeServe Blood Center to Implement Cutting-Edge Blood Product Inventory Management Ecosystem

The Technology has the Potential to Become the Standard of Care for Blood Supply Chain Management FOR IMMEDIATE RELEASE: ATLANTA, ...
Read more

Biolog-id raises 30 million euros from Funds managed by Xerys

Biolog-id, a global leader in the traceability and management of sensitive health products (red blood cells, plasma, platelets and chemotherapy ...
Read more